Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,200 Shares

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,200 shares of the firm's stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $63.89, for a total value of $140,558.00. Following the completion of the transaction, the executive vice president owned 140,610 shares of the company's stock, valued at approximately $8,983,572.90. This represents a 1.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.